Related Experiment Videos
Latest therapies for bipolar disorder. Looking beyond lithium
Joseph F Goldberg1, Leslie Citrome
1Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York, USA.
Postgraduate Medicine
|March 5, 2005
Summary
Bipolar disorder treatments now include anticonvulsants and antipsychotics, offering better tolerability and efficacy than lithium for certain states. Combination therapies and newer FDA-approved medications provide more options for managing this complex mood disorder.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Bipolar disorder management has evolved significantly.
- Lithium remains a key treatment but has limitations.
- Newer agents offer improved tolerability and efficacy for specific symptoms.
Purpose of the Study:
- To review current FDA-approved treatments for bipolar disorder.
- To highlight the role of anticonvulsants and antipsychotics.
- To discuss combination therapy and maintenance treatments.
Main Methods:
- Review of FDA-approved medications for bipolar disorder.
- Analysis of treatment efficacy and tolerability.
- Discussion of combination and maintenance strategies.
Main Results:
- Anticonvulsants and antipsychotics are effective alternatives to lithium for mixed states and rapid cycling.
- FDA-approved combination therapies exist for acute mania and depression.
- Olanzapine and lamotrigine are FDA-approved for maintenance treatment.
Conclusions:
- A wider range of effective treatments for bipolar disorder is now available.
- Combination therapy is frequently utilized for challenging cases.
- Off-label medications may be necessary for residual symptoms.